The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma

<p>Abstract</p> <p>Background</p> <p>Gallbladder cancer is the most common billiary tract malignancy and carries a very poor prognosis. Somatostatin was recently shown to play an important role in the development of various tumors. In the current study, we evaluated the...

Full description

Bibliographic Details
Main Authors: Liu Jian-Wen, Zhang Qiang, Quan Zhi-Wei, Li Ji-Yu
Format: Article
Language:English
Published: BMC 2007-07-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/7/125